Lates News

Pyxis Oncology (PYXS.US): In the Q3 financial report for 2025, revenue was 0 US dollars, unchanged from the previous value; earnings per share were -0.35 US dollars, also unchanged from the previous value, with an expected value of -0.35 US dollars.